| Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant (NCT00526292) | Memorial Sloan Kettering Cancer Center | 2007-08-01 |
| Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant (NCT00602446) | Masonic Cancer Center, University of Minnesota | 2007-08-01 |
| Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease (NCT00515892) | Cambridge Antibody Technology | 2007-08-01 |
| T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer (NCT00602693) | Masonic Cancer Center, University of Minnesota | 2007-07-23 |
| Cord Blood Expansion on Mesenchymal Stem Cells (NCT00498316) | M.D. Anderson Cancer Center | 2007-07-03 |
| Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell Vaccines (NCT00514189) | M.D. Anderson Cancer Center | 2007-07-01 |
| Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS) (NCT00480987) | M.D. Anderson Cancer Center | 2007-07-01 |
| Sirolimus in Combination With MEC in High Risk Myeloid Leukemias (NCT00780104) | Abramson Cancer Center at Penn Medicine | 2007-07-01 |
| Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant (NCT00510315) | Memorial Sloan Kettering Cancer Center | 2007-07-01 |
| Physical Activity in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy (NCT00554489) | Wake Forest University Health Sciences | 2007-07-01 |
| Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors (NCT00701844) | University of North Carolina, Chapel Hill | 2007-07-01 |
| Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes (NCT00641030) | City of Hope Medical Center | 2007-07-01 |
| Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT00469859) | Children's Oncology Group | 2007-06-01 |
| CEP-701 for PH-negative Myelofibrosis (NCT00494585) | M.D. Anderson Cancer Center | 2007-06-01 |
| S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia (NCT00492856) | SWOG Cancer Research Network | 2007-06-01 |
| Physical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT00499785) | Wake Forest University Health Sciences | 2007-06-01 |
| Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers (NCT00619645) | University of California, Davis | 2007-06-01 |
| Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias (NCT00472849) | M.D. Anderson Cancer Center | 2007-05-01 |
| Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies (NCT00473551) | M.D. Anderson Cancer Center | 2007-05-01 |
| Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer (NCT00369564) | University of South Florida | 2007-05-01 |
| Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy (NCT00416624) | Mayo Clinic | 2007-05-01 |
| Erwinase Study in Patients With Acute Lymphoblastic Leukemia (NCT00506597) | M.D. Anderson Cancer Center | 2007-05-01 |
| Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation (NCT00626626) | Milton S. Hershey Medical Center | 2007-05-01 |
| Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer (NCT00589563) | City of Hope Medical Center | 2007-05-01 |
| Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases (NCT00376519) | Masonic Cancer Center, University of Minnesota | 2007-05-01 |
| Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia (NCT00462332) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2007-05-01 |
| Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer (NCT00787761) | Northside Hospital, Inc. | 2007-04-01 |
| Studying Blood Samples in Young Patients With Cytopenia After a Donor Stem Cell Transplant (NCT00898118) | European Working Group of MDS in Childhood | 2007-04-01 |
| Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant (NCT00469820) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-04-01 |
| A Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy (NCT00362466) | Bristol-Myers Squibb | 2007-04-01 |
| Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease (NCT00462189) | Cambridge Antibody Technology | 2007-04-01 |
| Tipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia (NCT00101153) | University Health Network, Toronto | 2007-04-01 |
| Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia (NCT00462787) | Memorial Sloan Kettering Cancer Center | 2007-04-01 |
| Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 (NCT00466531) | Memorial Sloan Kettering Cancer Center | 2007-03-21 |
| Collecting and Storing Tissue From Young Patients With Cancer (NCT00898755) | Children's Oncology Group | 2007-03-05 |
| Vaccine Therapy in Treating Patients With Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia (NCT00466726) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2007-03-01 |
| PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy (NCT00335868) | Jonsson Comprehensive Cancer Center | 2007-03-01 |
| A Multi-Center Phase 2 Study of VEGF Trap as a Single Agent in Acute Myeloid Leukemia (NCT00601991) | Vanderbilt-Ingram Cancer Center | 2007-03-01 |
| Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia (NCT00372619) | Children's Oncology Group | 2007-03-01 |
| Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease (NCT00457860) | Cambridge Antibody Technology | 2007-03-01 |
| Autologous Stem Cell Transplants for Chronic Myelogenous Leukemia (NCT00446173) | M.D. Anderson Cancer Center | 2007-03-01 |
| Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer (NCT00806767) | Institut Paoli-Calmettes | 2007-03-01 |
| Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases (NCT00438958) | The Canadian Blood and Marrow Transplant Group | 2007-03-01 |
| Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment (NCT00458744) | Children's Oncology Group | 2007-02-01 |
| Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases (NCT00453206) | Wake Forest University Health Sciences | 2007-02-01 |
| Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes (NCT00234000) | Jonsson Comprehensive Cancer Center | 2007-02-01 |
| Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases (NCT00424242) | Northwestern University | 2007-01-01 |
| Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant (NCT00900406) | Vanderbilt-Ingram Cancer Center | 2007-01-01 |
| A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status (NCT00462761) | Daiichi Sankyo | 2007-01-01 |
| Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant (NCT00964821) | City of Hope Medical Center | 2007-01-01 |
| Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation (NCT00548847) | Emory University | 2007-01-01 |
| Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants (NCT00899327) | Oxford University Hospitals NHS Trust | 2007-01-01 |
| DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia (NCT00899366) | ECOG-ACRIN Cancer Research Group | 2006-12-28 |
| A Phase II Study of MK0457 in Patients With T315I Mutant CML and Ph+All (0457-008) (NCT00405054) | Merck Sharp & Dohme LLC | 2006-12-01 |
| Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia in Partial Remission or Complete Remission (NCT00458523) | Leeds Cancer Centre at St. James's University Hospital | 2006-12-01 |
| Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML) (NCT00422591) | M.D. Anderson Cancer Center | 2006-12-01 |
| Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R) (NCT00415857) | M.D. Anderson Cancer Center | 2006-12-01 |
| T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant (NCT00651716) | Vanderbilt-Ingram Cancer Center | 2006-12-01 |
| Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies (NCT00410982) | M.D. Anderson Cancer Center | 2006-12-01 |
| Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases (NCT00450983) | Fred Hutchinson Cancer Center | 2006-12-01 |
| Collection of Patient-Reported Symptoms and Performance Status Via the Internet (NCT00417040) | Alliance for Clinical Trials in Oncology | 2006-12-01 |
| Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00425802) | Memorial Sloan Kettering Cancer Center | 2006-11-28 |
| Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease (NCT00423514) | Memorial Sloan Kettering Cancer Center | 2006-11-20 |
| Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors (NCT00580281) | Memorial Sloan Kettering Cancer Center | 2006-11-01 |
| Natural Killer Cells in Older Patients With Acute Myeloid Leukemia (NCT00540956) | Institut Paoli-Calmettes | 2006-11-01 |
| AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors (NCT00415103) | PETHEMA Foundation | 2006-11-01 |
| Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia (NCT00886496) | Enzon Pharmaceuticals, Inc. | 2006-11-01 |
| Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia (NCT00425477) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-11-01 |
| Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes (NCT00045305) | Eastern Cooperative Oncology Group | 2006-10-24 |
| Combined Haploidentical-Cord Blood Transplantation for Adults and Children (NCT00943800) | University of Chicago | 2006-10-09 |
| S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT00337168) | SWOG Cancer Research Network | 2006-10-01 |
| Cyclophosphamide Plus T-Cell Transplantation for Patients With Hematologic Malignancies (NCT00356928) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-10-01 |
| Cellular Therapy With Cord Blood Cells (NCT00427557) | M.D. Anderson Cancer Center | 2006-10-01 |
| Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia (NCT00391560) | AEterna Zentaris | 2006-10-01 |
| Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma (NCT00398138) | Memorial Sloan Kettering Cancer Center | 2006-10-01 |
| RTA 744 Injection in Patients With Leptomeningeal Disease (NCT00512460) | M.D. Anderson Cancer Center | 2006-09-01 |
| Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI (NCT00363649) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-09-01 |
| Nutritional Assessment Intervention to Improve Cancer-Related Fatigue (NCT00507260) | M.D. Anderson Cancer Center | 2006-09-01 |
| Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance (NCT00581646) | Memorial Sloan Kettering Cancer Center | 2006-09-01 |
| Azacitidine, Darbepoetin Alfa, and Erythropoietin and Filgastrim (G-CSF) in Treating Patients With Myelodysplastic Syndromes (NCT00398047) | Wake Forest University Health Sciences | 2006-09-01 |
| Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation (NCT00383994) | M.D. Anderson Cancer Center | 2006-09-01 |
| Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD) (NCT00506948) | M.D. Anderson Cancer Center | 2006-09-01 |
| Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT (NCT01220297) | Stanford University | 2006-08-01 |
| Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825) (NCT00364286) | M.D. Anderson Cancer Center | 2006-08-01 |
| A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT (NCT00460421) | Swedish Orphan Biovitrum | 2006-08-01 |
| Cyclophosphamide and Rituximab Followed By Vaccine Therapy in Treating Patients With Chronic Lymphocytic Leukemia (NCT00343447) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-08-01 |
| Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes (NCT00454480) | The University of New South Wales | 2006-08-01 |
| Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT00372593) | Children's Oncology Group | 2006-08-01 |
| Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic Malignancies (NCT00642031) | Prescient Therapeutics, Ltd. | 2006-08-01 |
| Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT (NCT00350181) | Stanford University | 2006-08-01 |
| Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies (NCT00544466) | City of Hope Medical Center | 2006-07-31 |
| A Case-Cohort Study of Hematopoietic Malignancies and Related Disorders and Lung Cancer in Benzene-Exposed Workers in China (NCT00559065) | National Cancer Institute (NCI) | 2006-07-11 |
| Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma (NCT00387959) | Memorial Sloan Kettering Cancer Center | 2006-07-01 |
| Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens (NCT00419081) | BioCryst Pharmaceuticals | 2006-07-01 |
| Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant (NCT00410657) | Fred Hutchinson Cancer Center | 2006-07-01 |
| Velcade (Bortezomib - PS341) in the Treatment of Patients Over 18 Years With Ph+ Leukemia (NCT00511069) | University of Bologna | 2006-07-01 |
| Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLS (NCT00360438) | M.D. Anderson Cancer Center | 2006-07-01 |
| PR1 Vaccination in Myelodysplastic Syndrome (MDS) (NCT00893997) | M.D. Anderson Cancer Center | 2006-07-01 |
| Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment (NCT00416351) | Memorial Sloan Kettering Cancer Center | 2006-06-27 |
| Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies (NCT00476229) | M.D. Anderson Cancer Center | 2006-06-01 |